Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides reports best-ever full year performance for FY24 Strides declares a final dividend of Rs. 2.5 per share
22-05-2024
Bigul

Strides Pharma Science Ltd - 532531 - Corporate Action-Board approves Dividend

Recommendation of Final Dividend for FY ended March 31, 2024
22-05-2024
Bigul

Strides Pharma Science Ltd - 532531 - Outcome Of Board Meeting - May 22, 2024

Outcome of Board Meeting - May 22, 2024
22-05-2024
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10mL
22-05-2024
Bigul

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 - Rajagopalan J
21-05-2024
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Earnings Call for discussion of audited financial results for the quarter and year ended March 31, 2024
16-05-2024
Bigul

Strides Pharma Science Ltd - 532531 - Board Meeting Intimation for Announcement Of Board Meeting Under Regulation 29 Of SEBI Listing Regulations

Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 ,inter alia, to consider and approve Announcement of Board Meeting under Regulation 29 of SEBI Listing Regulations
14-05-2024
Bigul

Strides Pharma Science's shares rise 1.64% on USFDA approval

Strides Pharma Science's subsidiary Strides Pharma Global Pte Limited received USFDA's approval for Sevelamer Carbonate Tablets
10-05-2024
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800mg
10-05-2024
Next Page
Close

Let's Open Free Demat Account